<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MSJ</journal-id>
<journal-id journal-id-type="hwp">spmsj</journal-id>
<journal-id journal-id-type="nlm-ta">Mult Scler</journal-id>
<journal-title>Multiple Sclerosis Journal</journal-title>
<issn pub-type="ppub">1352-4585</issn>
<issn pub-type="epub">1477-0970</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1352458511414149</article-id>
<article-id pub-id-type="publisher-id">10.1177_1352458511414149</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Study</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cortical oscillopsia without nystagmus, an isolated symptom of neuromyelitis optica spectrum disorder with anti-aquaporin 4 antibody</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Sung-Min</given-names></name>
<xref ref-type="aff" rid="aff1-1352458511414149">1</xref>
<xref ref-type="aff" rid="aff2-1352458511414149">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Kim</surname><given-names>Ji-Soo</given-names></name>
<xref ref-type="aff" rid="aff1-1352458511414149">1</xref>
<xref ref-type="aff" rid="aff2-1352458511414149">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Heo</surname><given-names>Young Eun</given-names></name>
<xref ref-type="aff" rid="aff1-1352458511414149">1</xref>
<xref ref-type="aff" rid="aff2-1352458511414149">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yang</surname><given-names>Hye-Ran</given-names></name>
<xref ref-type="aff" rid="aff1-1352458511414149">1</xref>
<xref ref-type="aff" rid="aff2-1352458511414149">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Park</surname><given-names>Kyung Seok</given-names></name>
<xref ref-type="aff" rid="aff1-1352458511414149">1</xref>
<xref ref-type="aff" rid="aff2-1352458511414149">2</xref>
</contrib>
</contrib-group>
<aff id="aff1-1352458511414149"><label>1</label>Department of Neurology, Seoul National University, College of Medicine, Seoul, Korea.</aff>
<aff id="aff2-1352458511414149"><label>2</label>Department of Neurology, Seoul National University Bundang Hospital, Gyeonggi, Korea.</aff>
<author-notes>
<corresp id="corresp1-1352458511414149">Kyung Seok Park, Department of Neurology, Seoul National University, College of Medicine, Seoul, Korea Email: <email>pks1126@chol.com</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>2</month>
<year>2012</year>
</pub-date>
<volume>18</volume>
<issue>2</issue>
<fpage>244</fpage>
<lpage>247</lpage>
<history>
<date date-type="received">
<day>26</day>
<month>3</month>
<year>2011</year>
</date>
<date date-type="rev-recd">
<day>24</day>
<month>5</month>
<year>2011</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>5</month>
<year>2011</year>
</date>
</history>
<permissions>
<copyright-statement>© SAGE Publications 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Neuromyelitis optica (NMO), mainly affecting optic nerve and spinal cord, can also manifest diverse ocular symptoms due to brain abnormalities. We present a cortical oscillopsia without nystagmus or head tremor in a patient with neuromyelitis optica spectrum disorder (NMOSD) with anti-aquaporin 4 antibody. This rare ocular manifestation, which is easily underestimated owing to absence of the typical nystagmus, can be an initial manifestation of NMOSD.</p>
</abstract>
<kwd-group>
<kwd>cortical oscillopsia</kwd>
<kwd>MRI</kwd>
<kwd>neuromyelitis optica</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1352458511414149" sec-type="intro">
<title>Introduction</title>
<p>Oscillopsia has been observed in patients with multiple sclerosis<sup><xref ref-type="bibr" rid="bibr1-1352458511414149">1</xref>,<xref ref-type="bibr" rid="bibr2-1352458511414149">2</xref></sup> and neuromyelitis optica (NMO),<sup><xref ref-type="bibr" rid="bibr3-1352458511414149">3</xref></sup> mostly associated with nystagmus (due to ocular instability) and less frequently with head tremor,<sup><xref ref-type="bibr" rid="bibr2-1352458511414149">2</xref></sup> which are caused by brainstem or cerebellar lesions. However, oscillopsia without nystagmus caused only by cortical lesions (probably due to impaired spatial constancy) has not been reported in those diseases and its exact mechanism remains obscure.<sup><xref ref-type="bibr" rid="bibr4-1352458511414149">4</xref></sup></p>
<p>We present a case of cortical oscillopsia without nystagmus, in a patient of neuromyelitis optica spectrum disorder (NMOSD) with anti-aquaporin 4 antibody,<sup><xref ref-type="bibr" rid="bibr5-1352458511414149">5</xref></sup> which resolved with improvement of lesions involving the visual cortex area V5,<sup><xref ref-type="bibr" rid="bibr4-1352458511414149">4</xref>,<xref ref-type="bibr" rid="bibr6-1352458511414149">6</xref></sup> after plasmapheresis treatment.<sup><xref ref-type="bibr" rid="bibr7-1352458511414149">7</xref></sup></p>
</sec>
<sec id="section2-1352458511414149" sec-type="cases">
<title>Case report</title>
<p>A 45-year-old woman developed a visual illusion of the environment oscilliating with change in gaze position, beginning in September 2009. She felt that the margin of objects was not clear in her fixed head position. When she moved her gaze vertically or horizontally, she felt that objects oscillated to and fro with shifting afterimages in the opposite direction to her gaze movement. Her visual symptoms were brought on by both spontaneous gaze movement and gaze shift along with her head movement. She denied any decreased visual acuity, dysarthria, vertigo, nausea, vomiting, facial palsy, or sensorimotor symptoms including tonic–clonic movement. She had no previous medical history and was not taking any medication. Her blood pressure at admission was 134/84 mmHg. The ophthalmologic examination showed normal refractory ocular media, no relative afferent papillary defect, no papilledema, and normal visual acuity. Her visual symptoms did not improve with the pinhole test. The goldmann perimetry revealed mild bilateral inferior altitudinal hemianopia (<xref ref-type="fig" rid="fig1-1352458511414149">Figure 1</xref>). The neurological examination and/or video oculography did not show spontaneous or gaze-evoked nystagmus, head shaking nystagmus, corrective saccade with head impulse test, abnormal smooth pursuit, ocular misalignment, optic ataxia, oculomotor apraxia, extraocular muscle motion limitation, motor weakness, hypesthesia, or hyperactive deep tendon reflexes. Caloric testing and visual, brainstem, and somatosensory evoked potentials were all normal. She also underwent measurements of horizontal vestibule-ocular reflex (VOR) with the CHARTR rotatory vestibular test system (ICS medical), as described previously,<sup><xref ref-type="bibr" rid="bibr8-1352458511414149">8</xref></sup> and showed normal gains and phases of VOR.</p>
<fig id="fig1-1352458511414149" position="float">
<label>Figure 1.</label>
<caption>
<p>Goldmann perimetry of patient revealed mild bilateral inferior altitudinal hemianopsia.</p>
</caption>
<graphic xlink:href="10.1177_1352458511414149-fig1.tif"/>
</fig>
<p>Because she had oscillopsia without nystagmus or abnormal VOR<sup><xref ref-type="bibr" rid="bibr2-1352458511414149">2</xref>,<xref ref-type="bibr" rid="bibr4-1352458511414149">4</xref></sup> and mild bilateral inferior altitudinal hemianopia on goldmann perimetry,<sup><xref ref-type="bibr" rid="bibr9-1352458511414149">9</xref></sup> cortical lesions involving area V5<sup><xref ref-type="bibr" rid="bibr4-1352458511414149">4</xref>,<xref ref-type="bibr" rid="bibr6-1352458511414149">6</xref>,<xref ref-type="bibr" rid="bibr10-1352458511414149">10</xref></sup> and symmetric occipital or temporal lobe lesions in the optic radiations to upper lips of calcarine fissures<sup><xref ref-type="bibr" rid="bibr9-1352458511414149">9</xref></sup> were suspected as causing her visual symptoms. Magnetic resonance imaging (MRI) of the brain revealed diffuse bilateral T2-weighted high signal intensity (T2HSI) lesions in the corpus callosum, occipital lobes, and area V5, which resembled those of posterior reversible encephalopathy syndrome (PRES)<sup><xref ref-type="bibr" rid="bibr11-1352458511414149">11</xref>,<xref ref-type="bibr" rid="bibr12-1352458511414149">12</xref></sup> (<xref ref-type="fig" rid="fig2-1352458511414149">Figure 2A</xref>–<xref ref-type="fig" rid="fig2-1352458511414149">C</xref>). Although she had no ocular or oral symptoms of Sjögren’s syndrome, she tested positive for anti-SS-A antibodies. A 99m Tc-pertechnetate scan of the salivary glands showed mildly decreased excretory function of both submandibular glands, and the result of the Schirmer test was borderline (6 mm/7 mm in 5 min).<sup><xref ref-type="bibr" rid="bibr13-1352458511414149">13</xref></sup> Lumbar puncture revealed a normal opening pressure, no pleocytosis, and no oligoclonal band. Despite intravenous steroid treatment (1 g/day for 5 days), she reported worsening oscillopsia. MRI repeated in October 2010 revealed new enhancing lesions in the left occipital lobe and cloud-like enhancing lesions in the corpus callosum<sup><xref ref-type="bibr" rid="bibr11-1352458511414149">11</xref>,<xref ref-type="bibr" rid="bibr12-1352458511414149">12</xref></sup>(<xref ref-type="fig" rid="fig2-1352458511414149">Figure 2D</xref>–<xref ref-type="fig" rid="fig2-1352458511414149">H</xref>). The positive anti-SS-A antibody, decreased salivary gland function, cloud-like enhancements on MRI, and poor response to steroid were suggestive of NMOSD.<sup><xref ref-type="bibr" rid="bibr12-1352458511414149">12</xref>,<xref ref-type="bibr" rid="bibr13-1352458511414149">13</xref></sup> She was treated with plasmapheresis<sup><xref ref-type="bibr" rid="bibr7-1352458511414149">7</xref></sup> and her oscillopsia improved gradually. After 2 months, her oscillopsia had resolved completely, but she began to experience new lower extremity weakness and dizziness. Her spine MRI revealed a T2HSI lesion in the spinal cord at the T5 level involving mainly the gray matter of one vertebral segment length. In addition follow-up brain MRI also showed T2 HSI in the lower pons and periventricular white matter, while the previous lesions in the primary visual cortex and V5 were much improved (<xref ref-type="fig" rid="fig2-1352458511414149">Figure 2I</xref>–<xref ref-type="fig" rid="fig2-1352458511414149">K</xref>). After second attack, we tested her anti-aquaporin 4 antibody status at the Weatherall Institute of Molecular Medicine (Oxford, UK),<sup><xref ref-type="bibr" rid="bibr14-1352458511414149">14</xref></sup> using serum taken at the first attack and stored in a deep freezer (IRB NO. B-1007-105-401), which was positive. She was diagnosed as having NMOSD<sup><xref ref-type="bibr" rid="bibr5-1352458511414149">5</xref></sup> with anti-aquaporin 4 antibody and is being treated with azathioprine and low-dose oral steroid.</p>
<fig id="fig2-1352458511414149" position="float">
<label>Figure 2.</label>
<caption>
<p>Initial MRIs (A–C) revealed T2HSI lesions involving the corpus callosum and area V5. Follow up MRIs obtained after methylprednisolone treatment (D–H) showed new gadolinium enhancing lesions at the occipital lobe and corpus callosum with a cloud-like pattern (arrow, D), persistent T2HSI at the visual cortex (E, F), mild high signal intensity on diffusion weighted image at corpus callosum (G), and high ADC maps at the visual cortex (H). Second follow up MRIs (I–K), performed 2 months after treatment with plasmapheresis, showed a new lesion at the periventricular white matter (arrow, I), while the pre-existing lesions at the visual cortex have been decreased (J, K).</p>
</caption>
<graphic xlink:href="10.1177_1352458511414149-fig2.tif"/>
</fig>
</sec>
<sec id="section3-1352458511414149" sec-type="discussion">
<title>Discussion</title>
<p>We present a cortical oscillopsia without nystagmus as another manifestation of NMOSD with lesions of the visual cortex involving area V5.</p>
<p>Ocular instability, as impairment of ocular stabilizing system (acquired nystagmus, saccadic intrusion, pseudonystagmus with head tremor) or hyperactivity in the ocular motor or vestibular system (superior oblique myokymia, superior canal dehiscence syndrome),<sup><xref ref-type="bibr" rid="bibr1-1352458511414149">1</xref>,<xref ref-type="bibr" rid="bibr2-1352458511414149">2</xref>,<xref ref-type="bibr" rid="bibr4-1352458511414149">4</xref></sup> has been proposed to be a common cause of oscillopsia. However, our patient had no head tremor, nystagmus, abnormal saccades, paroxysmal ocular movements, or abnormal VOR.</p>
<p>Some studies have proposed that the impaired spatial constancy can also bring on oscillopsia in the absence of ocular instability.<sup><xref ref-type="bibr" rid="bibr4-1352458511414149">4</xref>,<xref ref-type="bibr" rid="bibr6-1352458511414149">6</xref>,<xref ref-type="bibr" rid="bibr10-1352458511414149">10</xref></sup> Though its mechanism is not still entirely clear, impairment of the visual cortex V5 and subsequent dysfunction of visuo-vestibular interactions has been suggested to be involved in its mechanism, as was the case of our patient, based on previous studies which showed that (1) the visual stimuli failed to activate area V5 in a patient with oscillopsia without nystagmus,<sup><xref ref-type="bibr" rid="bibr6-1352458511414149">6</xref></sup>(2) unilateral vestibular failure, causing oscillopsia during head movements, was associated with diminished activation of cortical visual motion-sensitive areas V5,<sup><xref ref-type="bibr" rid="bibr10-1352458511414149">10</xref></sup>(3) the area V5 corresponded to the parieto-insular vestibular cortex (PIVC) of the monkey which is supposed to be involved in the visuo-vestibular reflex.<sup><xref ref-type="bibr" rid="bibr15-1352458511414149">15</xref>,<xref ref-type="bibr" rid="bibr16-1352458511414149">16</xref></sup> In addition, the resolution of oscillopsia accompanying improvement of the lesions in area V5 in our patient also in turn supported the results of previous studies and hypotheses.</p>
<p>Despite the above-mentioned studies with functional images of patients<sup><xref ref-type="bibr" rid="bibr6-1352458511414149">6</xref>,<xref ref-type="bibr" rid="bibr10-1352458511414149">10</xref></sup> and experiments on animals,<sup><xref ref-type="bibr" rid="bibr16-1352458511414149">16</xref></sup> there has not been a one which showed that the structural lesion in area V5 of human subject can be involved in the oscillopsia without nystagmus. And this is also the first MRI report for cortical oscillopsia, in contrast to the previous ones with functional images only.<sup><xref ref-type="bibr" rid="bibr6-1352458511414149">6</xref>,<xref ref-type="bibr" rid="bibr10-1352458511414149">10</xref></sup></p>
<p>Oscillopsia, in the absence of typical nystagmus<sup><xref ref-type="bibr" rid="bibr1-1352458511414149">1</xref></sup> or head tremor,<sup><xref ref-type="bibr" rid="bibr2-1352458511414149">2</xref></sup> can be an initial manifestation of NMOSD, with lesions of the visual cortex involving area V5. This case also shows that cortical oscillopsia without nystagmus in NMO, which was intractable to steroid treatment, can be treated with plasmapheresis.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p>This work was supported by grant NO. 2010-0024457 from the National Research Foundation of Korea Fund and by grant NO. 800-20110047 from the Seoul National University, College of Medicine Research Fund.</p>
</fn>
<fn fn-type="conflict">
<p>None declared.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1352458511414149">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chen</surname><given-names>L</given-names></name>
<name><surname>Gordon</surname><given-names>LK</given-names></name>
</person-group>. <article-title>Ocular manifestations of multiple sclerosis</article-title>. <source>Curr Opin Ophthalmol</source> <year>2005</year>; <volume>16</volume>: <fpage>315</fpage>–<lpage>320</lpage>.</citation>
</ref>
<ref id="bibr2-1352458511414149">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Shaikh</surname><given-names>AG</given-names></name>
<name><surname>Reich</surname><given-names>S</given-names></name>
<name><surname>Zee</surname><given-names>DS</given-names></name>
</person-group>. <article-title>Pseudonystagmus – clinical features and quantitative characteristics</article-title>. <source>Nat Rev Neurol</source> <year>2010</year>; <volume>6</volume>: <fpage>519</fpage>–<lpage>523</lpage>.</citation>
</ref>
<ref id="bibr3-1352458511414149">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Samart</surname><given-names>K</given-names></name>
<name><surname>Phanthumchinda</surname><given-names>K</given-names></name>
</person-group>. <article-title>Neuromyelitis optica with hypothalamic involvement: A case report</article-title>. <source>J Med Assoc Thai</source> <year>2010</year>; <volume>93</volume>: <fpage>505</fpage>–<lpage>509</lpage>.</citation>
</ref>
<ref id="bibr4-1352458511414149">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tilikete</surname><given-names>C</given-names></name>
<name><surname>Vighetto</surname><given-names>A</given-names></name>
</person-group>. <article-title>Oscillopsia: causes and management</article-title>. <source>Curr Opin Neurol</source> <year>2011</year>; <volume>24</volume>: <fpage>38</fpage>–<lpage>43</lpage>.</citation>
</ref>
<ref id="bibr5-1352458511414149">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wingerchuk</surname><given-names>DM</given-names></name>
<name><surname>Lennon</surname><given-names>VA</given-names></name>
<name><surname>Lucchinetti</surname><given-names>CF</given-names></name>
<name><surname>Pittock</surname><given-names>SJ</given-names></name>
<name><surname>Weinshenker</surname><given-names>BG</given-names></name>
</person-group>. <article-title>The spectrum of neuromyelitis optica</article-title>. <source>Lancet Neurol</source> <year>2007</year>; <volume>6</volume>: <fpage>805</fpage>–<lpage>815</lpage>.</citation>
</ref>
<ref id="bibr6-1352458511414149">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Suzuki</surname><given-names>Y</given-names></name>
<name><surname>Kiyosawa</surname><given-names>M</given-names></name>
<name><surname>Mochizuki</surname><given-names>M</given-names></name>
<name><surname>Wakakura</surname><given-names>M</given-names></name>
<name><surname>Ishii</surname><given-names>K</given-names></name>
<name><surname>Senda</surname><given-names>M</given-names></name>
</person-group>. <article-title>Oscillopsia associated with dysfunction of visual cortex</article-title>. <source>Jpn J Ophthalmol</source> <year>2004</year>; <volume>48</volume>: <fpage>128</fpage>–<lpage>132</lpage>.</citation>
</ref>
<ref id="bibr7-1352458511414149">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pittock</surname><given-names>SJ</given-names></name>
</person-group>. <article-title>Neuromyelitis optica: a new perspective</article-title>. <source>Semin Neurol</source> <year>2008</year>; <volume>28</volume>: <fpage>95</fpage>–<lpage>104</lpage>.</citation>
</ref>
<ref id="bibr8-1352458511414149">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moon</surname><given-names>IS</given-names></name>
<name><surname>Kim</surname><given-names>JS</given-names></name>
<name><surname>Choi</surname><given-names>KD</given-names></name>
<etal/>
</person-group>. <article-title>Isolated nodular infarction</article-title>. <source>Stroke</source> <year>2009</year>; <volume>40</volume>: <fpage>487</fpage>–<lpage>491</lpage>.</citation>
</ref>
<ref id="bibr9-1352458511414149">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lakhanpal</surname><given-names>A</given-names></name>
<name><surname>Selhorst</surname><given-names>JB</given-names></name>
</person-group>. <article-title>Bilateral altitudinal visual fields</article-title>. <source>Ann Ophthalmol</source> <year>1990</year>; <volume>22</volume>: <fpage>112</fpage>–<lpage>117</lpage>.</citation>
</ref>
<ref id="bibr10-1352458511414149">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Deutschlander</surname><given-names>A</given-names></name>
<name><surname>Hufner</surname><given-names>K</given-names></name>
<name><surname>Kalla</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Unilateral vestibular failure suppresses cortical visual motion processing</article-title>. <source>Brain</source> <year>2008</year>; <volume>131</volume>: <fpage>1025</fpage>–<lpage>1034</lpage>.</citation>
</ref>
<ref id="bibr11-1352458511414149">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>JE</given-names></name>
<name><surname>Kim</surname><given-names>SM</given-names></name>
<name><surname>Ahn</surname><given-names>SW</given-names></name>
<etal/>
</person-group>. <article-title>Brain abnormalities in neuromyelitis optica</article-title>. <source>J Neurol Sci</source> <year>2011</year>; <volume>302</volume>: <fpage>43</fpage>–<lpage>48</lpage>.</citation>
</ref>
<ref id="bibr12-1352458511414149">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ito</surname><given-names>S</given-names></name>
<name><surname>Mori</surname><given-names>M</given-names></name>
<name><surname>Makino</surname><given-names>T</given-names></name>
<name><surname>Hayakawa</surname><given-names>S</given-names></name>
<name><surname>Kuwabara</surname><given-names>S</given-names></name>
</person-group>. <article-title>‘Cloud-like enhancement’ is a magnetic resonance imaging abnormality specific to neuromyelitis optica</article-title>. <source>Ann Neurol</source> <year>2009</year>; <volume>66</volume>: <fpage>425</fpage>–<lpage>428</lpage>.</citation>
</ref>
<ref id="bibr13-1352458511414149">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kim</surname><given-names>SM</given-names></name>
<name><surname>Waters</surname><given-names>P</given-names></name>
<name><surname>Vincent</surname><given-names>A</given-names></name>
<etal/>
</person-group>. <article-title>Sjögren’s syndrome myelopathy: spinal cord involvement in Sjögren’s syndrome might be a manifestation of neuromyelitis optica</article-title>. <source>Mult Scler</source> <year>2009</year>; <volume>15</volume>: <fpage>1062</fpage>–<lpage>1068</lpage>.</citation>
</ref>
<ref id="bibr14-1352458511414149">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Waters</surname><given-names>P</given-names></name>
<name><surname>Jarius</surname><given-names>S</given-names></name>
<name><surname>Littleton</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis</article-title>. <source>Arch Neurol</source> <year>2008</year>; <volume>65</volume>: <fpage>913</fpage>–<lpage>919</lpage>.</citation>
</ref>
<ref id="bibr15-1352458511414149">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grusser</surname><given-names>OJ</given-names></name>
<name><surname>Pause</surname><given-names>M</given-names></name>
<name><surname>Schreiter</surname><given-names>U</given-names></name>
</person-group>. <article-title>Vestibular neurones in the parieto-insular cortex of monkeys (Macaca fascicularis): visual and neck receptor responses</article-title>. <source>J Physiol</source> <year>1990</year>; <volume>430</volume>: <fpage>559</fpage>–<lpage>583</lpage>.</citation>
</ref>
<ref id="bibr16-1352458511414149">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Grusser</surname><given-names>OJ</given-names></name>
<name><surname>Pause</surname><given-names>M</given-names></name>
<name><surname>Schreiter</surname><given-names>U</given-names></name>
</person-group>. <article-title>Localization and responses of neurones in the parieto-insular vestibular cortex of awake monkeys (<italic>Macaca fascicularis</italic>)</article-title>. <source>J Physiol</source> <year>1990</year>; <volume>430</volume>: <fpage>537</fpage>–<lpage>557</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>